Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02296970 · ClinicalTrials.gov registry record
An Observational Study to Determine the Clinical Cure Rate of Therapeutic up Front Shave Removal of Basal Cell Carcinoma of the Skin With Long Term Follow up to Evaluate Recurrence
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 78
- Enrollment target
NCT02296970: Completed study, sponsored by University of Pittsburgh.
NCT02296970 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 78 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02296970 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 78 participants
- Enrollment target
Study Summary
Determine the effectiveness of a deep shave removal as a definitive treatment for basal cell carcinoma (BCC) without the need for a follow up surgical procedure.
Interventions
- PROCEDURE Deep shave removal using a blue surgical blade
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2014-12 |
| Est. Completion | 2018-12-31 |
What the finished NCT02296970 record still lists
NCT02296970 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 78 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Deep shave removal using a blue surgical blade is the first listed.
NCT02296970 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02296970 about?
NCT02296970 is a clinical study titled "An Observational Study to Determine the Clinical Cure Rate of Therapeutic up Front Shave Removal of Basal Cell Carcinoma of the Skin With Long Term Follow up to Evaluate Recurrence". Determine the effectiveness of a deep shave removal as a definitive treatment for basal cell carcinoma (BCC) without the need for a follow up surgical procedure.
What is the current status of trial NCT02296970?
This trial is currently completed. The enrollment target is 78 participants. The study started on 2014-12. Estimated completion is 2018-12-31.
What interventions are being tested in trial NCT02296970?
The interventions under investigation include: Deep shave removal using a blue surgical blade (PROCEDURE).
Who is sponsoring clinical trial NCT02296970?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02397668 · 78 participants · NA
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- NCT03321656 · 78 participants · Phase 2
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- NCT03687814 · 78 participants · NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- NCT04018872 · 78 participants · Phase 2
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia